Skip to main content

Advertisement

SpringerLink
Log in

Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

It has been estimated that the lifetime risk of breast cancer among women who inherit a BRCA1 or BRCA2 mutation is as high as 80%, and the risk estimates for ovarian cancer range from 15 to 40%. Several environmental and lifestyle factors are believed to contribute to the development of breast cancer in the general population and it is of interest to establish if these factors operate among mutation carriers as well. To evaluate the effects of age of menarche, parity, breast-feeding, oophorectomy and oral contraceptive use, as well as smoking and coffee consumption, on the risks of breast and ovarian cancer, we conducted a matched case–control study of Polish women with BRCA1 mutations. There were 348 breast cancer patients, 150 ovarian cancer patients and similar numbers of age-matched controls. BRCA1 carriers with late age of menarche, lower parity and long-term breast-feeding were less likely to develop breast cancer. Oral contraceptives protected against ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Easton DF, Ford D, Bishop DT, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium Am J Hum Genet 56: 265–271, 1995

    PubMed  CAS  Google Scholar 

  2. Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF, Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations a combined analysis of 22 population based studies. J Med Genet 42: 602–603 2005

    Article  PubMed  CAS  Google Scholar 

  3. Narod SA, Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2: 113–1232002

    Article  PubMed  Google Scholar 

  4. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72: 1117–1130, 2003

    Article  PubMed  CAS  Google Scholar 

  5. King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 24: 643–646, 2003

    Article  CAS  Google Scholar 

  6. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA, BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66: 1259–1272, 2000

    Article  PubMed  CAS  Google Scholar 

  7. Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 91: 1241–1247, 1999

    Article  PubMed  CAS  Google Scholar 

  8. Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA, Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22: 2328–2335, 2004

    Article  PubMed  CAS  Google Scholar 

  9. Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J, A high proportion of founder BRCA1 mutations in polish breast cancer families Int J Cancer 110: 683–686, 2004

    Article  PubMed  CAS  Google Scholar 

  10. Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA, and the Hereditary Breast Cancer Clinical Study Group. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer in press

  11. Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H, Hereditary Breast Cancer Clinical Study Group. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case–control study. Hereditary Breast Cancer Clinical Study Group Lancet 356: 1876–1881, 2000

    Article  PubMed  CAS  Google Scholar 

  12. Eisen A, Lubinski J, Klijn J, Moller P, Lynch H, Offit K, Weber B, Rebbeck T, Neuhausen S, Ghadirian P, Foulkes W, Gershoni-Baruch R, Friedman E, Rennert G, Isaacs C, Kim-Sing C, Ainsworth P, Couch F, Garber J, Daly M, Rosen B, Olopade O, Karlan B, Tung N, Saal H, Weitzel J, Eng C, Sun P, Narod SA: Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case–control study. J Clin Oncol (in press)

  13. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL, Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst 91: 1475–1479, 1999

    Article  PubMed  CAS  Google Scholar 

  14. Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Begin LR, Narod SA, Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type Clin Cancer Res 10: 2029–2034, 2004

    Article  PubMed  CAS  Google Scholar 

  15. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA: Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005 Jun 28; [Epub ahead of print]

  16. Narod SA, Sun P, Risch HA, Hereditary Ovarian Cancer Clinical Study Group. Ovarian cancer, oral contraceptives, and BRCA mutationsN Engl J Med 345: 1706–1707, 2001

    Article  PubMed  CAS  Google Scholar 

  17. Hopper JL, Baron JA, Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 95: 1010–1011, 2003

    PubMed  Google Scholar 

  18. Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS, Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations Br J Cancer 91: 1911–1915, 2004

    Article  PubMed  CAS  Google Scholar 

  19. Kelsey JL, Gammon MD, John EM, Reproductive factors and breast cancer Epidemiol Rev 15: 36–47, 1993

    PubMed  CAS  Google Scholar 

  20. Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen S, Ghadirian P, Isaacs C, Horsman D, Weber B, Foulkes WD, Ainsworth P, Daly M, Olopade O, Tung N, Saal H, Eisen A, Sun P, Narod SA, Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Cancer Causes Control 16: 667–674, 2005

    Article  PubMed  Google Scholar 

  21. Lipworth L, Bailey LR, Trichopoulos D, History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature J Natl Cancer Inst 92: 302–312, 2000

    Article  PubMed  CAS  Google Scholar 

  22. Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA, Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 96: 1094–1098, 2004

    Article  PubMed  CAS  Google Scholar 

  23. Ghadirian P, Lubinski J, Lynch H, Neuhausen SL, Weber B, Isaacs C, Baruch RG, Randall S, Ainsworth P, Friedman E, Horsman D, Tonin P, Foulkes WD, Tung N, Sun P, Narod SA, Smoking and the risk of breast cancer among carriers of BRCA mutations Int J Cancer 110: 413–416, 2004

    Article  PubMed  CAS  Google Scholar 

  24. Nkondjock A, Ghadirian P, Lubinski J, Lynch H, Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N, Eisen A, Friedman E, Eng C, Kotsopoulos J, Sun P, Narod SA: Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 2005 Jul 19 [Epub ahead of print]

Download references

Author information

Authors and Affiliations

  1. International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

    Jacek Gronwald, Tomasz Byrski, Tomasz Huzarski, Cezary Cybulski & Jan Lubinski

  2. Centre for Research in Womens Health, Sunnybrook and Womens’ College Health Sciences Center, University of Toronto, Toronto, Ontario, Canada

    Ping Sun, Anna Tulman & Steven A. Narod

  3. International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

    Jacek Gronwald

Authors
  1. Jacek Gronwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomasz Byrski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomasz Huzarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cezary Cybulski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ping Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna Tulman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Steven A. Narod
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jan Lubinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacek Gronwald.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gronwald, J., Byrski, T., Huzarski, T. et al. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat 95, 105–109 (2006). https://doi.org/10.1007/s10549-005-9051-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9051-5

Keywords

Search

Navigation